Psychofarmacology in the prevention of somatic comorbid diseases in mentally ill patients

Psychiatria Danubina

Volumn 21, Issue 3, 2009, Pages 350-355

  Jukić, Vlado ^a   Petrović, Zrinka ^a   Brečić, Petrana ^a   Krizaj, Aida ^a   Savić, Aleksandar ^a   Bačeković, Ana ^a   Bilić, Petar ^a   Sušac, Jelena ^a   Mandić, Antonija ^a   Pražen, Ivana ^a  

^a Psychiatric Hospital Vrap e   (Croatia)

Author keywords

Antipsychotics; Schizophrenia; Somatic comorbiditiy

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ANEMIA; BONE DISEASE; CARDIOVASCULAR DISEASE; COMORBIDITY; CONFERENCE PAPER; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIABETES MELLITUS; DYSLIPIDEMIA; ENDOCRINE DISEASE; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; HYPERTENSION; INFECTION; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MENTAL DISEASE; MENTAL PATIENT; METABOLIC DISORDER; MUSCLE DISEASE; OBESITY; PSYCHOPHARMACOLOGY; RESPIRATORY TRACT DISEASE; SCHIZOPHRENIA; SKIN DISEASE; SMOKING; SOMATOFORM DISORDER; SUBCUTANEOUS FAT DISORDER; TREATMENT OUTCOME; TUBERCULOSIS;

ADULT; ANTIPSYCHOTIC AGENTS; CARDIOVASCULAR DISEASES; COMMUNICABLE DISEASES; COMORBIDITY; CROATIA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SCHIZOPHRENIA; TUBERCULOSIS, PULMONARY;

EID: 70350327405     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Allebeck P: Schizophrenia: A Life- Shortening Disease. Schizophrenia Bulletin 1989; 15:81-89
2. American Diabetes Association, American Psychiatric Association, American association of Clinical Endocrinologists: Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 2004; 27: 596-601.
3. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. Washington, DC, American Psychiatric Association, 1994.
4. Brown S, Inskip H, Barraclough: Causes of excess mortality of schizophrenia. Br J Psychiatry 2000; 177: 212-217. (Pubitemid 30707552)
5. Busche CJ, Leonard B: Association between atypical antipsychotic agents and type 2 diabetes: review of prospective clinical data. B J Psych 2004; 160, 284-289.
6. Cassidy F, Ahearn E, Carroll BJ: Elevated frequency of diabetes mellitus in hospitalized psychiatric patients. Am J Psychiatry 1999; 156:1417-1420. (Pubitemid 29416540)
7. Crofton J, Horne N: Klinička tuberkuloza, Preface to 1st croatian edition, 2nd ed. Zagreb, IBS grafika, 2001.
8. Felker B, Yazel JJ, Short D: Mortality and medical comorbidity among psychiatric patients a review. Psychiatr Serv 1996; 47:1356-1363. (Pubitemid 26406073)
9. Fleischhacker W, Cetkovich-Bakmas M, De Hert M, Hennekens H, Lambert M, Leucht S et al.: Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy and research challenges. J Clin Psychiatry 2008; 69:514-519 (Pubitemid 351792324)
10. Goldman LS: Comorbid medical illness in psychiatric patients. Curr Psychiatry Rep 2000; 2:256-263.
11. Kishi Y, Kathol RG: Integrating medical and psychiatric treatment in an inpatient medical setting. The Type IV program. Psychosomatics 1999; 40:345-355.
12. Kohen D: Diabetes mellitus and schizophrenia: historical perspective. Br J Psychiatry 2004; 184:64-66.
13. Lyketsos CG, Dunn G, Kaminsky MJ, Breakey WR: Medical Comorbidity in Psychiatric Inpatients Relation to Clinical Outcomes and Hospital Length of Stay. Psychosomatics 2002; 43:24-30. (Pubitemid 34214158)
14. Oud M, Meyboom-de Jong B: Somatic diseases in patients with schizophrenia in general practice: their prevalence and health care. BMC Fam Pract 2009; 10:32.
15. Sternberg DE: Testing for physical illness in psychiatric patients. J Clin Psychiatry 1986; 47:3-9. (Pubitemid 16160140)